Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
17.6% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
20
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.1% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
17
users have liked this narrative
7
users have commented on this narrative
24
users have followed this narrative
10 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
4.7% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
45.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Inogen
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Aging Global Population And At-Home Care Will Boost Market Demand
Key Takeaways Portfolio expansion with bundled oxygen solutions and new product launches positions Inogen for sustained, accelerated growth and broader market leadership. Integration of digital health and international expansion supports higher customer value, recurring high-margin revenue, and substantial long-term profit potential.
View narrative
US$14.00
FV
47.4% undervalued
intrinsic discount
6.48%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 19 hours ago
author updated this narrative
Alta Equipment Group
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
US Infrastructure And Electrification Will Drive Equipment Demand
Key Takeaways Strategic focus on high-margin recurring services, automation, and efficiency drives margin expansion and positions Alta for accelerated revenue growth beyond current industry expectations. Robust liquidity and operational execution enable aggressive acquisitions and expansion, supporting market share gains as industry consolidation and fleet electrification trends intensify.
View narrative
US$20.00
FV
61.9% undervalued
intrinsic discount
3.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 19 hours ago
author updated this narrative
HomeToGo
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Remote Work And Emerging Travel Will Fuel B2B SaaS Growth
Key Takeaways Integration of strategic acquisitions and rapid product growth positions HomeToGo for sustained high-margin expansion, increased operating leverage, and strong multi-year revenue acceleration. Scalable B2B tech and payments infrastructure, plus global inventory reach, enable HomeToGo to capture rising online travel spend and lower acquisition costs compared to competitors.
View narrative
€5.20
FV
69.9% undervalued
intrinsic discount
32.55%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 19 hours ago
author updated this narrative
Silence Therapeutics
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Advancements In RNAi Will Harness Aging Healthcare Demand
Key Takeaways Strong clinical progress and unique program design could accelerate commercialization, market share gains, and pricing power, positioning Silence for significant margin and revenue growth. Expanding pipeline, regained global rights, and preclinical advances in RNAi therapeutics create long-term advantage and substantial high-margin revenue opportunities beyond current market expectations.
View narrative
US$74.31
FV
92.8% undervalued
intrinsic discount
40.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 19 hours ago
author updated this narrative
Beyond Meat
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Plant-Based Products Will Capture Secular Global Demand
Key Takeaways Expanded shelf presence and increased brand placement could rapidly accelerate retail sales, helping reclaim market share and boost revenue. Enhanced internal operations and clean-label innovation position Beyond Meat for improved margins and long-term, sustainable growth as consumer and institutional demand shifts.
View narrative
US$4.00
FV
39.8% undervalued
intrinsic discount
0.23%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 19 hours ago
author updated this narrative
Beyond
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Digital E-commerce Expansion And Premium Focus Will Unlock Potential
Key Takeaways Sharply focused shift to premium, high-end segments and affluent customers is set to accelerate revenue growth and drive outsized profitability gains. Strategic use of digital assets, e-commerce, and private label expansion positions Beyond for significant long-term margin improvement and upside optionality.
View narrative
US$17.00
FV
47.6% undervalued
intrinsic discount
17.39%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 19 hours ago
author updated this narrative
Cooper-Standard Holdings
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Electric Vehicle Adoption And Emissions Regulation Will Drive Demand
Key Takeaways Margin and earnings upside are likely as digital transformation and advanced manufacturing boost efficiency beyond current consensus expectations. Strong product pipeline, regulatory tailwinds, and advanced material innovation position the company for outsized revenue growth and continued pricing power.
View narrative
US$37.00
FV
20.3% undervalued
intrinsic discount
5.06%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 19 hours ago
author updated this narrative
Innoviz Technologies
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Autonomous And Smart Cities Will Accelerate LiDAR Adoption
Key Takeaways Rapid acceleration in bookings, strong OEM partnerships, and entry into diverse sectors position Innoviz for superior growth, recurring revenues, and market leadership in LiDAR. Scale advantages, high-value nonautomotive markets, and cost-lowering innovations are expected to significantly boost margins and speed up positive net earnings.
View narrative
US$4.00
FV
59.0% undervalued
intrinsic discount
134.51%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 19 hours ago
author updated this narrative
Synthomer
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
Urban Expansion And Eco Policies Will Spur Specialty Chemicals
Key Takeaways Specialization in higher-margin products, site reduction, and broader divestments accelerate deleveraging, capital efficiency, and stronger cash flow growth. Global expansion and industry partnerships position Synthomer for superior revenue, margin growth, and reduced geographic risk amid rising sustainable material demand.
View narrative
UK£3.48
FV
81.9% undervalued
intrinsic discount
6.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 19 hours ago
author updated this narrative
Value any company in seconds
Popular companies